COST

967.63

+2.93%↑

PG

153.19

+0.88%↑

STZ

155.58

-0.75%↓

GIS

45.61

-1.32%↓

MKC

61.04

-1.37%↓

COST

967.63

+2.93%↑

PG

153.19

+0.88%↑

STZ

155.58

-0.75%↓

GIS

45.61

-1.32%↓

MKC

61.04

-1.37%↓

COST

967.63

+2.93%↑

PG

153.19

+0.88%↑

STZ

155.58

-0.75%↓

GIS

45.61

-1.32%↓

MKC

61.04

-1.37%↓

COST

967.63

+2.93%↑

PG

153.19

+0.88%↑

STZ

155.58

-0.75%↓

GIS

45.61

-1.32%↓

MKC

61.04

-1.37%↓

COST

967.63

+2.93%↑

PG

153.19

+0.88%↑

STZ

155.58

-0.75%↓

GIS

45.61

-1.32%↓

MKC

61.04

-1.37%↓

Search

USANA Health Sciences Inc

Закрыт

21.6 -0.64

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

20.77

Макс.

21.96

Ключевые показатели

By Trading Economics

Доход

-17M

-6.7M

Продажи

-22M

214M

P/E

Средняя по отрасли

24.689

29.619

Прибыль на акцию

-0.15

Рентабельность продаж

-3.118

Сотрудники

1,700

EBITDA

-17M

11M

Дивиденды

By Dow Jones

Следующий отчет о доходах

17 февр. 2026 г.

Рыночная статистика

By TradingEconomics

Рыночная капитализация

25M

406M

Предыдущая цена открытия

22.24

Предыдущая цена закрытия

21.6

Техническая оценка

By Trading Central

Уверенность

Weak Bullish Evidence

USANA Health Sciences Inc График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

2 февр. 2026 г., 23:52 UTC

Приобретения, слияния, поглощения

Elliott Management Doesn't Plan to Tender Its Shares at the Current Terms

2 февр. 2026 г., 23:52 UTC

Приобретения, слияния, поглощения

Elliott Management: Toyota Fudosan Revised Tender Offer for Toyota Industries 'Very Significantly Undervalues' Company

2 февр. 2026 г., 23:48 UTC

Обсуждения рынка

Nikkei May Rise on Signs of U.S. Economic Strength -- Market Talk

2 февр. 2026 г., 23:38 UTC

Обсуждения рынка

Gold Rises on Likely Technical Recovery, Dip-Buying Interest -- Market Talk

2 февр. 2026 г., 23:28 UTC

Обсуждения рынка

SpaceX, xAI Deal Further Consolidates Musk's Businesses -- Market Talk

2 февр. 2026 г., 23:23 UTC

Отчет

Palantir Achieves Another Revenue Record With $1.41 Billion Quarter -- 2nd Update

2 февр. 2026 г., 22:57 UTC

Отчет

Palantir Reports Strong Earnings. The Stock Is Rising. -- Barrons.com

2 февр. 2026 г., 22:22 UTC

Приобретения, слияния, поглощения

What the Blockbuster SpaceX--xAI Merger Can Mean for Tesla Stock -- Barrons.com

2 февр. 2026 г., 22:08 UTC

Обсуждения рынка

Australian Inflation Woes Rooted In Excess Govt Spending -- Market Talk

2 февр. 2026 г., 21:51 UTC

Отчет

Palantir Reports Strong Earnings. The Stock Is Rising. -- Barrons.com

2 февр. 2026 г., 21:50 UTC

Обсуждения рынка

Basic Materials Roundup: Market Talk

2 февр. 2026 г., 21:49 UTC

Отчет

Disney's Streaming Profit Surges as CEO Decision Approaches -- 5th Update

2 февр. 2026 г., 21:39 UTC

Отчет

Palantir Reports Strong Earnings. The Stock Is Rising. -- Barrons.com

2 февр. 2026 г., 21:36 UTC

Отчет

Palantir Achieves Another Revenue Record With $1.41 Billion Quarter -- Update

2 февр. 2026 г., 21:34 UTC

Отчет

Palantir Reports Strong Earnings. The Stock Is Rising. -- Barrons.com

2 февр. 2026 г., 21:28 UTC

Приобретения, слияния, поглощения

What a SpaceX--xAI Merger Could Mean for Tesla Stock -- Barrons.com

2 февр. 2026 г., 21:23 UTC

Отчет

BYD, Chinese EV Stock Plunge On Weak Data. What That Means for Tesla Stock. -- Barrons.com

2 февр. 2026 г., 21:19 UTC

Отчет

Palantir Technologies: U.S. Commercial Business Growing at 'Astonishing' Rate, Generating $507 Million Last Quarter, 137% Increase Over the Same Period the Year Before >PLTR

2 февр. 2026 г., 21:17 UTC

Отчет

Palantir Achieves Another Revenue Record With $1.41 Billion Quarter -- WSJ

2 февр. 2026 г., 21:17 UTC

Отчет

Palantir Reports Strong Earnings. The Stock Is Rising. -- Barrons.com

2 февр. 2026 г., 21:10 UTC

Отчет

Palantir Reports Strong Earnings. The Stock Is Rising. -- Barrons.com

2 февр. 2026 г., 21:08 UTC

Отчет

Palantir Technologies: Rule of 40 Score Is Now 127% >PLTR

2 февр. 2026 г., 21:07 UTC

Отчет

Palantir Technologies: Sees 2026 U.S. Comml Rev in Excess of $3.144B, Representing Growth Rate of at Least 115% >PLTR

2 февр. 2026 г., 21:05 UTC

Отчет

Palantir Technologies 4Q Net $608.7M >PLTR

2 февр. 2026 г., 21:05 UTC

Отчет

Palantir Technologies 4Q Rev $1.41B >PLTR

2 февр. 2026 г., 21:05 UTC

Отчет

Palantir Technologies Sees 1Q Rev $1.53B-$1.54B >PLTR

2 февр. 2026 г., 21:05 UTC

Отчет

Palantir Technologies Sees FY Rev $7.18B-$7.2B >PLTR

2 февр. 2026 г., 21:05 UTC

Отчет

Palantir Technologies 4Q Adj EPS 25c >PLTR

2 февр. 2026 г., 21:05 UTC

Отчет

Palantir Technologies 4Q EPS 24c >PLTR

2 февр. 2026 г., 20:40 UTC

Обсуждения рынка

Treasury Yields, Dollar Rise Amid Signs of Resilient U.S. Economy -- Market Talk

Сравнение c конкурентами

Изменение цены

USANA Health Sciences Inc Прогноз

Консенсус по рейтингу

By TipRanks

0 ratings

0

Покупка

0

Удержание

0

Продажа

Техническая оценка

By Trading Central

28.405 / 29.84Поддержка и Сопротивление

Краткосрочная

Weak Bullish Evidence

Среднесрочная

Bullish Evidence

Долгосрочная

No Evidence

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании USANA Health Sciences Inc

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products through retail stores and online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.
help-icon Live chat